Two Sigma Securities’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,469
Closed -$42K – 2610
2021
Q4
$42K Buy
+1,469
New +$57.5K ﹤0.01% 1302
2019
Q2
– Sell
-1,283
Closed -$68K – 2497
2019
Q1
$68K Buy
+1,283
New +$64K ﹤0.01% 1598

Other funds holding ORGS

Two Sigma Securities's ORGS Position: Q1 2022 in Review

Two Sigma Securities sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2022, closing a stake of 1,469 shares — an estimated $42K sold.

Two Sigma Securities first reported a position in ORGS in Q1 2019 and held it in 2 quarters. The position peaked at $68K in Q1 2019. 22 funds tracked by Wall St. Rank hold ORGS as of Q1 2022.

  • Two Sigma Securities reported no remaining Orgenesis Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,469 Orgenesis Inc. Common Stock shares in Q1 2022, an estimated $42K.
  • Two Sigma Securities first reported a position in Orgenesis Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Two Sigma Securities's Orgenesis Inc. Common Stock position peaked at $68K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.